https://imedic.health/en/health/news/fda-expands-cosentyx-use-hidradenitis-suppurativa iMedic en 2026-10-26 Cosentyx for Hidradenitis Suppurativa: What FDA Expansion Means https://imedic.health/en/health/news/newborn-metabolic-formula-access-fda-safety-review iMedic en 2026-10-26 Newborn Metabolic Formula Access: What the FDA’s Safety Review Means https://imedic.health/en/health/news/melanoma-personalized-mrna-vaccine-immunotherapy-recurrence iMedic en 2026-10-26 Personalized Melanoma Vaccine: How It May Strengthen Immunotherapy https://imedic.health/en/health/news/ixekizumab-chronic-skin-condition-fda-expanded-use iMedic en 2026-10-26 FDA Expands Novartis Drug Use for Chronic Skin Disease: What Patients Should Know https://imedic.health/en/health/news/weltruzа-olanzapine-monthly-injection-fda-approval iMedic en 2026-10-26 Monthly Olanzapine Injection: What the FDA Approval Means for Schizophrenia Treatment